Safety and cross-neutralization capacity of a Sabin strain-based inactivated polio vaccine: a randomized, double-blind, positive-control clinical trial in 2-month-old infants
The Sabin strain-based inactivated poliovirus vaccine (sIPV) assists in completely eradicating poliovirus transmission, especially in developing countries. Sera from sIPV-immunized individuals can neutralize wild poliovirus strains, primarily indicating its protective potential, though clinical efficacy data are...